- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.06. | Clinical Laserthermia Systems AB: Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB | 111 | GlobeNewswire (Europe) | Today, June 29th, 2026 the Annual General Meeting (the "AGM") of Clinical Laserthermia Systems AB, 556705-8903, was held. Below is a summary of the decisions taken. All decisions were taken with the... ► Artikel lesen | |
| 04.06. | Clinical Laserthermia Systems publishes annual report for 2025 | 1 | Cision News | ||
| 28.05. | Clinical Laserthermia Systems AB: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 2026 | 2 | Cision News | ||
| CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 12.05. | Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - March 2026 | 199 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - March 2026.Highlights of First Quarter Interim Report 2026
During the... ► Artikel lesen | |
| 28.04. | Clinical Laserthermia Systems AB: CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT | 211 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (CLS) today announced it has reached an agreement with its strategic partner on an alignment to accelerate the growth of the ClearPoint Prism® business. The plan includes... ► Artikel lesen | |
| 20.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025 | 316 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its Year-end report for January - December 2025.Highlights of the Year-end report 2025The year 2025 represents... ► Artikel lesen | |
| 12.12.25 | Clinical Laserthermia Systems AB: CLS initiates recruitment process for permanent Chief Financial Officer | 262 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS") today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a permanent and fully employed... ► Artikel lesen | |
| 14.11.25 | Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - September 2025 | 964 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - September 2025.Highlights of the Third Quarter Interim ReportDuring the... ► Artikel lesen | |
| 07.10.25 | Clinical Laserthermia Systems AB: CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | 220 | GlobeNewswire (Europe) | Lund, Sweden, October 7th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS") today announces positive results from a clinical safety study on laser ablation, performed using CLS proprietary LITT... ► Artikel lesen | |
| 04.09.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 366 | GlobeNewswire (Europe) | Lund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for expansion... ► Artikel lesen | |
| 22.08.25 | Clinical Laserthermia Systems AB: CLS publishes half-year report January - June 2025 | 338 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report January - June 2025. Second Quarter Highlights
Record sales revenue of SEK 9,4M... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 41,020 | 0,00 % | DAX-Check LIVE: DHL Group, Fresenius, Rheinmetall, SAP, Talanx | Die Rekordjagd des DAX scheint erst einmal ausgebremst. Gestern setzte es ein deutliches Minus. Auch heute geht es erst einmal nach unten. Die Vorgaben aus Asien und den USA sind überwiegend schwach.... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,480 | 0,00 % | AKTIE IM FOKUS: Carl Zeiss Meditec wieder gefragt - Metzler: Erholungsignale | FRANKFURT (dpa-AFX) - Die Aktien von Carl Zeiss Meditec haben es am Mittwoch im schwachen Markt mit 29,90 Euro wieder fast an ihr Monatshoch herangeschafft. Dabei gewannen die Papiere der Jenaer bis... ► Artikel lesen | |
| INTUITIVE SURGICAL | 335,95 | +1,08 % | Here's Exactly Why Intuitive Surgical Stock Is Floundering in 2026 | ||
| DRAEGERWERK | 83,40 | 0,00 % | DAX-Check LIVE: Brenntag, Deutsche Bank, Drägerwerk, Evotec, Puma, Volkswagen Vz. im Fokus | Der deutsche Aktienmarkt hat den Wochenauftakt trotz neuer Turbulenzen im Nahen Osten mit einem knappen Plus beendet. Der DAX ging 0,2 Prozent fester bei 25.114 Punkten aus dem Handel und verteidigte... ► Artikel lesen | |
| MEDTRONIC | 69,58 | +0,20 % | Medtronic warns on Harmony transcatheter pulmonary valve delivery system | ||
| THERMO FISHER | 466,10 | -0,41 % | Persistence Market Research Pvt. Ltd.: Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG | LONDON, July 8, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient... ► Artikel lesen | |
| TELADOC HEALTH | 8,078 | -0,42 % | Teladoc (TDOC) Rises Higher Than Market: Key Facts | ||
| HIMS & HERS HEALTH | 30,900 | +0,46 % | Truist reiterates Hold on Hims and Hers stock, $23 target on peptide uncertainty | ||
| SERNOVA BIOTHERAPEUTICS | 0,067 | -4,00 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| DEXCOM | 64,00 | -1,54 % | Dexcom receives Health Canada authorization for G7 15 Day CGM | ||
| ALCON | 58,78 | +0,38 % | Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know | ||
| RESMED | 169,80 | +0,44 % | Health Check: Restless investors question sleep giant Resmed's short-term prospects | ||
| HEALWELL AI | 0,444 | +1,03 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,290 | 0,00 % | Siemens Healthineers: Berenberg wird vorsichtiger | Die Analysten der Privatbank Berenberg haben ihr Kursziel für Siemens Healthineers von 54 auf 39 € gesenkt und die Einstufung von "Buy" auf "Hold" reduziert. Die Begründung: Bei den Faktoren, die dem... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,400 | 0,00 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen |
Das Unternehmen CLINICAL LASERTHERMIA SYSTEMS AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,72 % bei einem Aktienkurs von 0,257 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLINICAL LASERTHERMIA SYSTEMS AB finden Sie auf Wallstreet Online.